Novo Nordisk stock has fallen roughly 40% from a peak it reached last June. The U.S. Food and Drug Administration recently confirmed Novo Nordisk is producing enough Ozempic and Wegovy to meet ...

The FDA today declared the national deficit of GLP-1 diet drugs at an end. Well, at least for Novo Nordisk's Ozempic and Wegovy. Novo Nordisk sales should be going up, and Hims & Hers Health's ...

Now, semaglutide maker Novo Nordisk is chiming in. The commercial takes aim at the broader U.S. weight loss industry as well as makers of GLP-1 drugs for obesity, which are “priced for profits ...

In September, Volkswagen will unveil the electric T-Cross at IAA Mobility, dubbed the ID.2X. CEO Thomas Schäfer confirmed the mini electric SUV’s name on Thursday, which is expected to go in ...

Jerry Jones and the Dallas Cowboys are in a tough position entering the NFL offseason. After missing the playoffs in 2024, the team has moved on from Mike McCarthy, but they don't have a lot of ...

Novo Holdings' $16.5 billion acquisition of US contract development and manufacturing organisation (CDMO) Catalent has been completed, after months of debate over potential antitrust issues.

We recently published a list of the 10 Best Drug Stocks to Buy Now. In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against other best drug stocks to buy now.

Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and diabetes, saying the drug is too complex to be made safely ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...